KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $121.6 million.

  • Eli Lilly's Short-term Investments fell 1860.78% to $121.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.6 million, marking a year-over-year decrease of 1860.78%. This contributed to the annual value of $154.8 million for FY2024, which is 4188.82% up from last year.
  • Per Eli Lilly's latest filing, its Short-term Investments stood at $121.6 million for Q3 2025, which was down 1860.78% from $170.1 million recorded in Q2 2025.
  • Eli Lilly's Short-term Investments' 5-year high stood at $170.1 million during Q2 2025, with a 5-year trough of $37.1 million in Q3 2021.
  • Over the past 5 years, Eli Lilly's median Short-term Investments value was $123.4 million (recorded in 2023), while the average stood at $115.3 million.
  • The largest annual percentage gain for Eli Lilly's Short-term Investments in the last 5 years was 27231.4% (2021), contrasted with its biggest fall of 3750.0% (2021).
  • Eli Lilly's Short-term Investments (Quarter) stood at $90.1 million in 2021, then skyrocketed by 60.71% to $144.8 million in 2022, then fell by 24.65% to $109.1 million in 2023, then soared by 41.89% to $154.8 million in 2024, then fell by 21.45% to $121.6 million in 2025.
  • Its Short-term Investments was $121.6 million in Q3 2025, compared to $170.1 million in Q2 2025 and $127.4 million in Q1 2025.